Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Revenue

Shanghai Serum Bio-Technology had revenue of 27.09M CNY in the quarter ending March 31, 2026, with 5.75% growth. This brings the company's revenue in the last twelve months to 197.68M, up 1.77% year-over-year. In the year 2025, Shanghai Serum Bio-Technology had annual revenue of 196.21M with 0.66% growth.

• Revenue (ttm): 197.68M
• Revenue Growth: +1.77%
• P/S Ratio: 21.89
• Revenue / Employee: 606.37K
• Employees: 324
• Market Cap: 4.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	196.21M	1.29M	0.66%
Dec 31, 2024	194.92M	4.77M	2.51%
Dec 31, 2023	190.14M	15.92M	9.14%
Dec 31, 2022	174.22M	-34.47M	-16.52%
Dec 31, 2021	208.69M	23.13M	12.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error